Nanosphere (NSPH)
Nanosphere Revenues: 1.299M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
NSPH Revenues Rankings
| Overall | 2nd percentile | 4302 of 4432 |
| Sector | 13th percentile | 407 of 471 in Healthcare |
| Industry | 11th percentile | 60 of 68 in Medical Instruments & Supplies |
NSPH Revenues Range, Past 5 Years
| Minimum | 0.1882M | Dec 2007 |
| Maximum | 1.299M | Mar 2012 |
| Average | 0.5168M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these NSPH related companies
NSPH News
$NSPH forms bearish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/3qV8
about 15 days ago by RecogniaEvents
about 15 days ago by RecogniaEvents
Nanosphere Enters Into Marketing and Distribution Agreement in Europe With Thermo Fisher Scientific
Apr 30, 8:36AM GlobeNewswire
Apr 30, 8:36AM GlobeNewswire
$NSPH Some good results out of $NSPH from a few recently published studies: 1) http://stks.co/3XXF
2) http://stks.co/3XXG
about 35 days ago by LongRun
about 35 days ago by LongRun
Nanosphere to Release Q1 2012 Results and Hold Investor Call on Tuesday, May 1
Apr 18, 11:59AM GlobeNewswire
Apr 18, 11:59AM GlobeNewswire
$NSPH 30 systems placed in 4Q- could be the start of a long term upswing (8 placed in 3Q - 12 2Q)
about 105 days ago by LongRun
about 105 days ago by LongRun
Nanosphere to Release Q4 and Full Year 2011 Results and Hold Investor Call on Thursday, February 16
Feb 06, 4:52PM GlobeNewswire
Feb 06, 4:52PM GlobeNewswire
New Long Setups To Watch http://stks.co/1h8s $GOOG $ALXN $NSPH $OCLR
about 156 days ago by ACInvestorBlog
about 156 days ago by ACInvestorBlog
$NSPH ...the FDA approval was only a test and not a drug so dont stay long on the scalp trade spike up IMHO..hot money will come n go $Study
about 156 days ago by EXPstocktrader
about 156 days ago by EXPstocktrader
Nanosphere (NSPH) Shares Surge 16% Upon FDA Clearance of Gram-Positive Blood Culture Test
Dec 27, 2:28PM Street Insider
Dec 27, 2:28PM Street Insider
$NSPH shares now up 17+% following FDA clearance of Gram-Positive blood culture test
about 156 days ago by Street_Insider
about 156 days ago by Street_Insider
Nanosphere (NSPH) Gets FDA 501(k) Clearance for Verigene Staphylococcus BC-S
Dec 27, 2:26PM Street Insider
Dec 27, 2:26PM Street Insider
Nanosphere Receives FDA Clearance of Gram-Positive Blood Culture Test for Staphylococcus
Dec 27, 2:25PM Benzinga
Dec 27, 2:25PM Benzinga
Nanosphere (NSPH) Gets CE IVD Mark for Gram-Positive BC-GP on Verigene
Dec 20, 5:27PM Street Insider
Dec 20, 5:27PM Street Insider
Nanosphere to Present at Piper Jaffray 23rd Annual Healthcare Conference
Nov 29, 1:07PM GlobeNewswire
Nov 29, 1:07PM GlobeNewswire
$NSPH http://stks.co/14v3 i'm biased, but this one has one of the best looking chart in small #BIOTECHS imho
about 203 days ago by LTbioinvestor
about 203 days ago by LTbioinvestor
$NSPH had 3 insider buys last week of Sep, then a major buy in Oct. Up from 0.97 to to 1.36. Made $YHOO gainers list lst wk, still going up
about 220 days ago by WatchInsiders
about 220 days ago by WatchInsiders
$NSPH http://stks.co/jcd On watch list from yesterday now over 50-day EMA but also over Top Bollinger band so protect profits
about 223 days ago by StockTiger
about 223 days ago by StockTiger
$NSPH http://stks.co/iiz low priced one on watch list between lines vol 88% of full day
about 224 days ago by StockTiger
about 224 days ago by StockTiger
$NSPH http://stks.co/hsE low priced can be volatile but good for quicker trade at least on good volume
about 224 days ago by StockTiger
about 224 days ago by StockTiger
Market Wrap Video + Additions to Watch List http://stks.co/hn7 including $KMB $NSPH $PIP $FSII $HNI $MTG $DETR $VNO
about 225 days ago by StockTiger
about 225 days ago by StockTiger
Nanosphere to Release Q3 2011 Results and Hold Investor Call on Wednesday, November 2
Oct 18, 1:00PM GlobeNewswire
Oct 18, 1:00PM GlobeNewswire
Nanosphere Verigene test shows high sensitivity for a broad panel of targets
Sep 19, 4:19PM FlyOnTheWall
Sep 19, 4:19PM FlyOnTheWall
New Emerging Medical Opportunities reports 5.2% passive stake in Nanosphere
Aug 16, 3:55PM FlyOnTheWall
Aug 16, 3:55PM FlyOnTheWall
Nanosphere, Inc. (NSPH) Posts Q2 EPS Loss of $0.23, Revenues Miss Consensus
Aug 09, 4:12PM Street Insider
Aug 09, 4:12PM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NSPH | 1.68 | -0.01 | -0.59% | 74.04M |
| NSP | 24.83 | -0.37 | -1.47% | 639.12M |
| NSIT | 14.99 | -0.68 | -4.34% | 658.81M |
| NSH | 32.25 | -0.56 | -1.71% | 1.373B |
| NSFC | 0.70 | +0.01 | +1.45% | |
| NSEC | 9.53 | +1.01 | +11.85% | 23.54M |
| NSC | 65.34 | -1.16 | -1.74% | 22.68B |
| NS | 52.66 | -0.97 | -1.81% | 3.726B |
| NRT | 29.82 | -0.74 | -2.42% | 274.05M |
| NRP | 23.01 | -0.62 | -2.62% | 2.440B |
